Merck , Centech, The Venture Collective, CQDMOther

Merck Digital Sciences Studio (MDSS) – 2026 Accelerator Program

This one has closed

Archived

Opportunity type

Other

Funding

Fully Funded

Location

Global

Deadline

Archived

About this opportunity

The MDSS is a nine‑month accelerator designed to help startups scale digital solutions for drug discovery and development. Key features:

SAFE investment from Merck Global Health Innovation Fund (GHI)
Mentorship from Merck experts and Centech advisors
Azure Cloud computing credits to accelerate R&D
Access to Merck scientists for piloting technologies in discovery and clinical settings
Networking with investors, pharma leaders, and innovation hubs in the US and Canada
Focus areas: AI/ML for drug discovery, digital biomarkers, clinical trial optimization, translational medicine platforms

Early‑stage startups (Seed – Series A)
Focus on digital health or biotech innovation aligned with Merck’s therapeutic areas
Must demonstrate:
Validated MVP or prototype
Potential for scalability and clinical impact
Must submit:
Online application form
Pitch deck and business plan
Evidence of team capacity

LOT finds and checks opportunities from public sources. Always confirm details on the organiser’s own page before applying.

Merck , Centech, The Venture Collective, CQDMOther

This one has closed

Archived

Opportunity type

Other

Funding

Fully Funded

Location

Global

Deadline

Archived

The MDSS is a nine‑month accelerator designed to help startups scale digital solutions for drug discovery and development. Key features:

SAFE investment from Merck Global Health Innovation Fund (GHI)
Mentorship from Merck experts and Centech advisors
Azure Cloud computing credits to accelerate R&D
Access to Merck scientists for piloting technologies in discovery and clinical settings
Networking with investors, pharma leaders, and innovation hubs in the US and Canada
Focus areas: AI/ML for drug discovery, digital biomarkers, clinical trial optimization, translational medicine platforms

Early‑stage startups (Seed – Series A)
Focus on digital health or biotech innovation aligned with Merck’s therapeutic areas
Must demonstrate:
Validated MVP or prototype
Potential for scalability and clinical impact
Must submit:
Online application form
Pitch deck and business plan
Evidence of team capacity

LOT finds and checks opportunities from public sources. Always confirm details on the organiser’s own page before applying.